DSO vs Independent: The Real Financial Trade-Off

When you are sitting across from a DSO’s M&A team and they slide a letter of intent across the table, the number on that page means nothing unless you understand how your dental practice valuation was constructed — and what it would look like if you walked away and scaled independently instead. This is not a philosophical choice between freedom and security. It is a financial modeling exercise with a right and a wrong answer that is specific to your practice’s current numbers.

The Core Decision in Plain Numbers

A dental practice owner generating $800K in annual EBITDA who sells to a DSO today at a 5x multiple walks away with $4M. That same owner who scales independently to $2M EBITDA over the next five years and then sells at an 8x multiple walks away with $16M — a $12M difference that almost no one calculates before they sign.

That gap is the entire argument for this article. The right answer depends on your current EBITDA, your operational infrastructure, your risk tolerance, and your timeline. But the math has to come first — before the attorneys, before the consultants, and before you let a DSO’s pitch deck frame the conversation on their terms.

A rigorous dental practice valuation is the starting point for every decision that follows. It tells you what you are worth today, what you could be worth in three to seven years if you scale independently, and whether a DSO’s offer is actually competitive or whether it is discounted because of gaps in your infrastructure that you have the power to close.

EBITDA Multiples and Why Scale Changes Everything

The single most misunderstood variable in any dental practice acquisition conversation is the relationship between EBITDA level and the multiple a buyer will apply — and the compression that happens below certain thresholds is severe enough to reshape the entire decision.

Here is what the market actually looks like. Practices generating below $500K in EBITDA typically receive offers in the 3x to 5x range. Practices at $500K to $1M EBITDA move into the 5x to 7x band. Once a dental group crosses $1M in EBITDA — and especially as it approaches $2M or more — the multiple can reach 7x to 10x or higher, depending on geography, payer mix, and operational maturity. That is not a linear increase. It is an exponential one.

What drives the multiple beyond just raw EBITDA? Payer mix matters enormously. Practices with fee-for-service revenue exceeding 60% of total collections consistently command premium multiples because they carry lower insurance dependency risk. Geography plays a role — DSOs pay more for practices in high-density suburban and metro markets where patient acquisition costs are predictable. Clinical team stability, associate retention, and the degree to which the owner has removed themselves from production all affect where in the range a specific offer lands.

The practical implication is this: if you are currently at $700K EBITDA and a DSO offers you 6x, you are looking at a $4.2M deal. If you spend the next four years building the infrastructure to reach $1.5M EBITDA — through a second or third location, tighter overhead management, and associate-driven production — you can approach that same conversation with a valuation of $9M to $12M. The question is whether you have the operational discipline and the financial runway to execute that path.

Equity Rollover Mechanics Most Dentists Never Model

Equity rollover — where the selling dentist retains 20% to 40% ownership in the combined DSO entity post-close — is often the most financially valuable component of a modern DSO deal, yet it is also the least understood by the dentists who sign those agreements.

Here is how it works. When a DSO acquires your practice, they do not always pay 100% cash at close. In many deals, particularly those backed by private equity, they pay 60% to 80% in cash and offer the remainder as equity in the DSO’s holding company or a regional roll-up entity. If that DSO subsequently sells to a larger platform or takes a liquidity event — typically within three to seven years — your retained equity is valued at the new, higher multiple applied to the combined entity’s EBITDA.

The upside is real. If you roll 30% of a $5M deal — keeping $1.5M in DSO equity — and the DSO sells three years later at a valuation that represents a 2x return on your stake, you have generated an additional $1.5M on top of the $3.5M cash you received at close. The downside is equally real: DSO equity is illiquid, the future sale is not guaranteed, and the management decisions that drive the DSO’s value after your close are no longer yours to make. You are betting on someone else’s execution. Before you accept any rollover structure, you need to understand the DSO’s current leverage ratio, their existing portfolio EBITDA, and what their private equity sponsor’s timeline for exit looks like.

Earnout Provisions and the Hidden Costs of a DSO Deal

Earnout provisions are one of the most commonly misunderstood — and financially dangerous — components of a dental practice acquisition, and competitors almost never explain the real downside risk they carry for the selling dentist.

An earnout is a contractual clause that makes a portion of the purchase price contingent on the practice hitting defined performance targets after the deal closes — typically over 12 to 36 months. On paper, it sounds reasonable. In practice, it creates a situation where you have sold your practice, ceded operational control, and are now dependent on the DSO’s management decisions to unlock the remaining portion of your purchase price. If the DSO implements scheduling changes, billing protocols, or staffing structures that reduce your practice’s production — even temporarily — you may forfeit a meaningful slice of your deal value with no recourse.

The hidden cost compounds further when you factor in transition obligations. Many DSO agreements require the seller to remain clinically active for two to four years post-close, often at a compensation rate that is lower than what the dentist earned as an owner. The delta between your owner compensation and your post-sale employment compensation is a real economic cost that rarely appears in the headline multiple calculation. A dentist who earned $450K annually as an owner but accepts a $280K associate role post-close is absorbing a $170K annual opportunity cost — over four years, that is $680K that should be subtracted from the gross deal value before you compare it to any independent scaling projection.

The Independent Scaling Path and When It Wins

Independent multi-location scaling consistently produces superior financial outcomes for dental owners who have the operational infrastructure, financial discipline, and five-to-seven-year planning horizon to execute it — but most owners underestimate the capital requirements and overestimate the speed.

The financial architecture for independent expansion is more accessible than most dentists realize. The SBA 504 loan program allows dental practice owners to finance owner-occupied real estate and equipment for expansion locations up to $5.5M at below-market fixed rates, with as little as 10% down. Combined with practice cash flow as the operating reserve, an owner-operator with a well-run flagship location can realistically open a second location within 18 to 24 months without outside equity and without surrendering any ownership stake.

The independent path also preserves optionality. An owner who builds a three-location group independently retains 100% equity appreciation during the growth phase, controls clinical standards, and dictates the timing and terms of any future exit. When they do approach DSO buyers — at a much higher EBITDA level — they enter that conversation with negotiating leverage rather than desperation. The DSO needs their scale and operational maturity. That dynamic fundamentally changes the deal structure available to them.

The data supports this approach. A dental practice owner who starts at $600K EBITDA, opens two additional locations over five years, optimizes overhead to maintain a 25-28% EBITDA margin on $6M in collections, and reaches $1.5M EBITDA before entering DSO conversations can reasonably model an 8x to 9x exit. Compare that to selling at $600K EBITDA today at 5x — the difference is $10M or more in terminal value, before accounting for the five years of owner compensation and equity building along the way.

Operational Prerequisites for Either Path

Neither a DSO partnership nor independent scaling is available to a dentist who is still functioning as the primary producer in their practice — both paths require the owner to have built a management layer that can operate without their clinical presence.

This is the piece that competitors almost never address directly, but it is the operational gate that determines which conversation you can even have. DSO buyers discount or walk away from practices where the owner is generating more than 60-70% of clinical production. The rationale is simple: if you leave, the revenue leaves. That is not a scalable business — it is a job that happens to carry a practice name.

The management infrastructure that makes a practice DSO-attractive — or independently scalable — includes a non-clinical operations director or practice administrator who manages scheduling, staffing, and financial reporting. It includes standardized clinical protocols that allow associate dentists to produce at consistent levels. It includes a centralized scheduling and patient communications system, a defined case acceptance workflow, and a hygiene department that runs on its own production metrics. Without these systems, you are not selling a business. You are selling your personal production capacity with a building attached.

Building this infrastructure takes 12 to 36 months for most practice owners. It requires investment in people, systems, and the willingness to temporarily reduce owner take-home while the management layer is funded. But it is the investment that unlocks either path. A practice with this infrastructure is worth more to a DSO buyer, commands a higher multiple in an independent sale, and can support a second or third location without the owner physically being present across all chairs simultaneously.

The Decision Framework: A Step-by-Step Model

The right decision between DSO partnership and independent scaling is not about which option sounds better — it is the output of a five-variable financial model that every multi-location dental owner should run before entering any acquisition conversation.

Start with your current EBITDA. Calculate it accurately — not your gross collections, not your owner compensation, but your true EBITDA after normalizing for owner salary at market rate and adding back non-recurring expenses. If you do not know this number within 5%, stop here and run the financial model with your accountant before proceeding. Everything downstream depends on this anchor.

1. 01.Calculate your current normalized EBITDA — adjust owner compensation to market rate ($200K–$280K), add back one-time expenses, and confirm your EBITDA margin against collections.
2. 02.Model the DSO offer range — apply the multiple table above to your current EBITDA. Calculate cash-at-close after subtracting rollover equity. Subtract post-close compensation gap over your required transition period.
3. 03.Model the independent scaling path — project EBITDA at your 5-year target assuming one to two additional locations. Apply a conservative 7x exit multiple to the projected EBITDA. Subtract total capital required for expansion. Add five years of owner compensation during growth phase.
4. 04.Assess your operational readiness — score your management infrastructure honestly. If you cannot scale independently without rebuilding systems from scratch, the DSO path may be the more realistic option regardless of which pencils out higher.
5. 05.Apply a risk-adjusted discount — the independent scaling model carries execution risk that the DSO deal does not. Apply a 20-30% risk discount to your independent scaling terminal value before comparing the two paths. If the discounted independent number still exceeds the DSO offer by more than $2M, the case for scaling is strong.

The decision framework is not complete without one more variable: your personal timeline. A 52-year-old dentist with a $700K EBITDA practice and a 10-year runway faces a different calculation than a 38-year-old with the same numbers. The independent scaling path requires time to compound. If your horizon is shorter than five years, the math often shifts toward the DSO deal — not because it is philosophically superior, but because you do not have enough runway to capture the full value of the scaling premium.

For deeper context on how the dental entrepreneur community approaches multi-location scaling decisions and DSO negotiations, the resources at the Dental Entrepreneur Organization offer peer-level perspective from group practice owners who have navigated both paths. The ADA’s practice resources also provide benchmark data useful for normalizing your financial model against industry averages before entering any acquisition conversation.

Frequently Asked Questions

Last updated: July 2025